A carregar...
Efficacy and safety of rivastigmine in patients with Alzheimer’s disease: international randomised controlled trial
OBJECTIVES: To assess the effects of rivastigmine on the core domains of Alzheimer’s disease. DESIGN: Prospective, randomised, multicentre, double blind, placebo controlled, parallel group trial. Patients received either placebo, 1-4 mg/day (lower dose) rivastigmine, or 6-12 mg/day (higher dose) riv...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
1999
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC27767/ https://ncbi.nlm.nih.gov/pubmed/10066203 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|